Pulmonary Fibrosis

Pulmonary fibrosis is a chronic lung disease marked by progressive scarring of lung tissue, which impairs oxygen exchange and causes symptoms like breathlessness and fatigue. In 2025, research is advancing rapidly, with promising clinical trials exploring new inhaled, injectable and oral therapies. Scientists are also investigating immune cell proteins that may reverse lung scarring.  

While current treatments focus on slowing disease progression and improving quality of life, lung transplantation remains a critical option for advanced cases. Early diagnosis and multidisciplinary care are essential for better outcomes.